Status:
UNKNOWN
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
Lead Sponsor:
Inonu University
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18-80 years
Brief Summary
Evaluation of plasma angiotensin II and angiotensin II receptor levels in patients with sepsis and septic shock: a prospective observational study.
Detailed Description
There is an increasing number of experimental publications investigated effects of angiotensin II and receptors on the pathogenesis and treatment of sepsis and septic shock. However, its level in huma...
Eligibility Criteria
Inclusion
- intensive care unit patient
Exclusion
- End-stage organ failure,
- immunodeficiency, vasospastic disease, pregnancy, other shock causes (hypovolemic, cardiogenic, neurogenic) a life expectancy of less than 48 hours
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04716842
Start Date
January 1 2021
End Date
April 1 2021
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ayse Belin B OZER
Malatya, Turkey (Türkiye)